Address Confusion About Biosimilars

December 2018

You'll see a growing list of biosimilars.

Examples include Nivestym or Zarxio for Neupogen (filgrastim)...and Retacrit for Epogen or Procrit (epoetin alfa).

Biosimilars are also approved for Enbrel, Humira, and others...but aren't yet available due to legal disputes or other issues.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Table of Contents

Opioids Focus on De-Escalation and Safe-Use Strategies for Opioids
Antibiotics Answer Questions About the New Antibiotic Eravacycline
Hemophilia Sort Through Meds for Managing Hemophilia
New Drugs Don't Use Baloxavir to Treat Patients Hospitalized With the Flu
Antithrombotics Stay Alert for Low-Dose Rivaroxaban for Coronary or Peripheral Artery Disease
Pediatrics Prepare for Questions About Treating Croup
New Drugs Feel Comfortable Holding CGRP Antagonist Meds for Migraine Prophylaxis
Raynaud's Help Limit Attacks When Patients With Raynaud's Are Admitted
Biosimilars Address Confusion About Biosimilars